The Board remands the claims for further development, including obtaining additional medical opinions and private treatment records.
The deciding factor: The decision is based on the need to obtain a more comprehensive medical opinion that considers the legal standards set forth in Spicer v. McDonough, 61 F.4th 1360 (Fed. Cir. 2023), and to ensure compliance with VA's duty to assist.
- Claimed conditions
- squamous cell cancer of the skin, chloracne
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- November 20, 2025
- Citation
- A25100864
Veterans Law Judge
Decisions by this judge: 734 · Granted: 31% (granted or partly granted, in the vetted decisions on this site)
Judge attribution: 2025 complete; earlier years partial.
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation A25100864.
What this means for you
A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Remanded (sent back)
The Board has denied the Veteran's claims for service connection for aortic aneurysm secondary to his service-connected hypertension, squamous cell cancer of the skin, and benign prostatic hyperplasia. The issues of entitlement to compensable ratings for hypertension and colon cancer residuals are also remanded due to potential impact on the issue of a 10 percent evaluation based on multiple noncompensable service-connected disabilities.
- Remanded (sent back)
The Veteran's spouse is seeking to be substituted as the appellant for claims of service connection filed by the Veteran in August 2017. The AOJ has not yet determined whether she meets the requirements to substitute, and this issue must be remanded.
- Granted
The Veteran's chloracne is presumed to be caused by his exposure to herbicide agents during service, and the Board has granted service connection for this condition.
- Denied
The Veteran's claim for an initial disability rating in excess of 10 percent for chloracne with pilonidal cyst associated with TERA participation was denied, and the claim for an effective date prior to July 29, 2024, for service connection was also denied.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.